NME1 and inflammatory bowel disease: Although we provided compelling evidence using this macrophage depletion and reconstitution system, more approaches such as the genetically engineered mouse model are warranted to confirm RHOH and NME1 in macrophages are potential therapeutic targets for IBD management.